ATE251174T1 - Synthese von markierten oligonucleotiden auf festphasenträgern - Google Patents

Synthese von markierten oligonucleotiden auf festphasenträgern

Info

Publication number
ATE251174T1
ATE251174T1 AT00911866T AT00911866T ATE251174T1 AT E251174 T1 ATE251174 T1 AT E251174T1 AT 00911866 T AT00911866 T AT 00911866T AT 00911866 T AT00911866 T AT 00911866T AT E251174 T1 ATE251174 T1 AT E251174T1
Authority
AT
Austria
Prior art keywords
solid
support
label
acid
labelled
Prior art date
Application number
AT00911866T
Other languages
English (en)
Inventor
Ravi S Vinayak
Linda G Lee
Khairuzzaman B Mullah
Barnett B Rosenblum
Original Assignee
Applera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applera Corp filed Critical Applera Corp
Application granted granted Critical
Publication of ATE251174T1 publication Critical patent/ATE251174T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00911866T 1999-02-22 2000-02-18 Synthese von markierten oligonucleotiden auf festphasenträgern ATE251174T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/256,340 US6255476B1 (en) 1999-02-22 1999-02-22 Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
PCT/US2000/004213 WO2000050432A2 (en) 1999-02-22 2000-02-18 Synthesis of labelled oligonucleotides on solid-supports

Publications (1)

Publication Number Publication Date
ATE251174T1 true ATE251174T1 (de) 2003-10-15

Family

ID=22971883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911866T ATE251174T1 (de) 1999-02-22 2000-02-18 Synthese von markierten oligonucleotiden auf festphasenträgern

Country Status (10)

Country Link
US (5) US6255476B1 (de)
EP (1) EP1155027B1 (de)
JP (4) JP4634615B2 (de)
AT (1) ATE251174T1 (de)
AU (1) AU773864B2 (de)
CA (1) CA2353047C (de)
DE (1) DE60005646T2 (de)
DK (1) DK1155027T3 (de)
ES (1) ES2204537T3 (de)
WO (1) WO2000050432A2 (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881570B1 (en) * 1998-12-15 2005-04-19 Fuji Photo Film Co., Ltd. Test piece and quantitative method and apparatus for an organism-oriented substance
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
JP3957118B2 (ja) * 1999-05-18 2007-08-15 富士フイルム株式会社 試験片およびこの試験片からの画像情報読取装置
US6593464B1 (en) * 1999-05-24 2003-07-15 Invitrogen Corporation Method for deblocking of labeled oligonucleotides
US7183405B2 (en) * 1999-06-25 2007-02-27 Syn Gen, Inc. Compositions and methods for labeling oligonucleotides
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6451588B1 (en) * 2000-06-30 2002-09-17 Pe Corporation (Ny) Multipartite high-affinity nucleic acid probes
JP3398366B2 (ja) * 2000-08-09 2003-04-21 富士写真フイルム株式会社 Ｄｎａ分析用マイクロアレイの製造方法
US6559279B1 (en) 2000-09-08 2003-05-06 Isis Pharmaceuticals, Inc. Process for preparing peptide derivatized oligomeric compounds
WO2002048404A2 (en) * 2000-12-14 2002-06-20 Gen-Probe Incorporated Method and kit for enhancing the association rates of polynucleotides
US6534646B2 (en) 2001-06-04 2003-03-18 Barrskogen, Inc. Oligonucleotide labeling reagents
US6448016B1 (en) * 2001-06-12 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences for detection of Bacillus anthracis
WO2003004690A2 (en) * 2001-07-06 2003-01-16 454$m(3) CORPORATION Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US20030054396A1 (en) * 2001-09-07 2003-03-20 Weiner Michael P. Enzymatic light amplification
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en) 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050124022A1 (en) * 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6946245B2 (en) 2001-12-04 2005-09-20 Quest Diagnostics Investments Incorporated Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
US6686162B2 (en) 2001-12-04 2004-02-03 Quest Diagnostics Investments, Incorporated Oligonucleotides and methods for detecting Borrelia burgdorferi
DE10206616A1 (de) * 2002-02-15 2003-09-04 Qiagen Gmbh Verfahren zur Reduktion der Background-Kontamination nach Markierungsreaktionen
CA2498320A1 (en) * 2002-09-20 2004-04-01 Integrated Dna Technologies, Inc. Anthraquinone quencher dyes, their methods of preparation and use
US6913890B2 (en) * 2002-12-18 2005-07-05 Palo Alto Research Center Incorporated Process for preparing albumin protein conjugated oligonucleotide probes
US20060292438A1 (en) * 2002-12-23 2006-12-28 Applera Corporation; Applied Biosystems Group Heteroconfigurational Polynucleotides and Methods of Use
US20080015349A1 (en) * 2003-01-24 2008-01-17 Third Wave Technologies, Inc. Oligonucleotide production
US7575865B2 (en) * 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
CA2513899C (en) * 2003-01-29 2013-03-26 454 Corporation Methods of amplifying and sequencing nucleic acids
EP1466919A1 (de) * 2003-04-05 2004-10-13 Roche Diagnostics GmbH Sechsgliedrige Ringe Nukleotidanalogue
CA2463719A1 (en) * 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
WO2005049849A2 (en) 2003-11-14 2005-06-02 Integrated Dna Technologies, Inc. Fluorescence quenching azo dyes, their methods of preparation and use
US20050153300A1 (en) * 2004-01-09 2005-07-14 Quest Diagnostics Incorporated Methods and compositions for the detection of mucolipidosis IV mutations
US20050214779A1 (en) * 2004-03-29 2005-09-29 Peck Bill J Methods for in situ generation of nucleic acid arrays
EP1627926A1 (de) * 2004-08-19 2006-02-22 Roche Diagnostics GmbH Eine Methode zur Reduktion von falsch-positiven Messergebnissen
US7879569B2 (en) 2004-11-09 2011-02-01 The Trustees Of The University Of Pennsylvania Methods for diagnosis of myelodysplastic syndromes (MDS)
JP2008545659A (ja) 2005-05-20 2008-12-18 インテグレイテッド ディーエヌエイ テクノロジーズ インコーポレイテッド オリゴヌクレオチドを標識する化合物及び方法
WO2007024798A2 (en) 2005-08-22 2007-03-01 Applera Corporation Apparatus, system, and method using immiscible-fluid-discrete-volumes
DE502005008153D1 (de) 2005-11-23 2009-10-29 Roche Diagnostics Gmbh Polynukleotid mit Phosphatmimetikum
US20070218490A1 (en) * 2006-03-15 2007-09-20 Integrated Dna Technologies, Inc. Nucleic acid monomers with 2'-chemical moieties
CN101454315B (zh) * 2006-03-31 2016-08-17 应用生物系统有限责任公司 用于合成罗丹明-标记的寡核苷酸的试剂
CA2649770C (en) 2006-04-18 2017-08-15 The Trustees Of The University Of Pennsylvania Mutated acvr1 for diagnosis and treatment of fibrodysplasia ossificans progressiva (fop)
US8859752B2 (en) 2006-04-18 2014-10-14 The Trustees Of The University Of Pennsylvania SIRNA-based therapy of Fibrodyplasia Ossificans Progressiva (FOP)
US7759062B2 (en) * 2006-06-09 2010-07-20 Third Wave Technologies, Inc. T-structure invasive cleavage assays, consistent nucleic acid dispensing, and low level target nucleic acid detection
US20080153135A1 (en) * 2006-12-20 2008-06-26 Liu Timothy Z Methods and apparatus for conducting amplification reactions on high density hydrophilic patterned microplates
US20080153134A1 (en) * 2006-12-22 2008-06-26 Willy Wiyatno Methods and apparatus for generating hydrophilic patterning of high density microplates using an amphiphilic polymer
US20080268440A1 (en) * 2007-04-26 2008-10-30 Liu Timothy Z Biomolecule immobilization on surface via hydrophobic interactions
EP2036897B1 (de) * 2007-09-04 2017-10-18 Roche Diagnostics GmbH Stabiles Reagens zur Rhodaminmarkierung
WO2009038791A1 (en) 2007-09-18 2009-03-26 Applied Biosystems Inc. Methods, systems and apparatus for light concentrating mechanisms
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods
JP5365005B2 (ja) * 2008-01-17 2013-12-11 富士通株式会社 中性で切断可能な核酸合成用レジン
WO2009117327A2 (en) 2008-03-15 2009-09-24 Hologic, Inc. Compositions and methods for analysis of nucleic acid molecules during amplification reactions
JP5438922B2 (ja) * 2008-06-25 2014-03-12 日東電工株式会社 核酸の製造方法
US8097412B2 (en) * 2008-07-12 2012-01-17 Biodiagnostics, Inc. DNA-based test for detection of annual and intermediate ryegrass
EP2192198A1 (de) 2008-12-01 2010-06-02 Biotype AG Neuartige Kombination von Fluoreszenzfarbstoffen zur Erkennung von Nukleinsäuren
US9347092B2 (en) 2009-02-25 2016-05-24 Roche Molecular System, Inc. Solid support for high-throughput nucleic acid analysis
WO2011035135A1 (en) 2009-09-18 2011-03-24 The Trustees Of The University Of Pennsylvania Novel molecular beacons
US20110146418A1 (en) * 2009-10-02 2011-06-23 Brevnov Maxim G Sample Preparation Devices and Methods
WO2011066330A2 (en) * 2009-11-24 2011-06-03 Life Technologies Corporation Selective amplification of polynucleotide sequences
US9506057B2 (en) 2010-03-26 2016-11-29 Integrated Dna Technologies, Inc. Modifications for antisense compounds
EP2553123B1 (de) 2010-03-26 2016-08-24 Integrated DNA Technologies, Inc. Verfahren zur verstärkung einer nukleinsäurehybridisierung
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
AU2011299233B2 (en) 2010-09-07 2016-09-15 Integrated Dna Technologies, Inc. Modifications for antisense compounds
EP2625189B1 (de) 2010-10-01 2018-06-27 ModernaTX, Inc. Manipulierte nukleinsäuren und anwendungsverfahren dafür
US9777332B2 (en) 2011-03-31 2017-10-03 St. Jude Children's Research Hospital Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
JP5808025B2 (ja) * 2011-08-12 2015-11-10 国立研究開発法人産業技術総合研究所 アミノ化オリゴヌクレオチド用固相担体
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DE19216461T1 (de) 2011-10-03 2021-10-07 Modernatx, Inc. Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
CA3018046A1 (en) 2011-12-16 2013-06-20 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
EP3228715B1 (de) 2012-02-09 2019-08-14 Life Technologies Corporation Konjugiertes polymerteilchen und herstellungsverfahren dafür
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US8859098B2 (en) * 2012-05-18 2014-10-14 Lord Corporation Acrylic adhesion promoters
CN104822845B (zh) 2012-10-15 2019-02-26 素德赫·辛哈 用于使用散在遗传元件进行遗传检测的方法：多路复合的dna分析系统
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
WO2014158628A1 (en) 2013-03-14 2014-10-02 Hologic, Inc. Compositions and methods for analysis of nucleic acid molecules
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
EP3041934A1 (de) 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Chimäre polynukleotide
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052521A1 (de) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynukleotide zur codierung von low-density-lipoprotein-rezeptor
US20150132256A1 (en) * 2013-10-19 2015-05-14 Trovagene, Inc. Detecting and monitoring mutations in histiocytosis
HK1222209A1 (zh) * 2013-10-19 2017-06-23 Trovagene, Inc. 隨時間檢測疾病中的突變
WO2015179790A1 (en) * 2014-05-23 2015-11-26 Centrillion Technology Holding Corporation Oligonucleotide probe inversion process for in situ synthesized probe arrays
US20170204152A1 (en) 2014-07-16 2017-07-20 Moderna Therapeutics, Inc. Chimeric polynucleotides
EP3171895A1 (de) 2014-07-23 2017-05-31 Modernatx, Inc. Modifizierte polynukleotide zur herstellung von intrabodys
CN107922974B (zh) 2015-07-02 2021-11-09 生命技术公司 羧基官能亲水微珠的偶合
EP3320115B1 (de) * 2015-07-06 2020-09-02 Life Technologies Corporation Substrat und verfahren zur sequenzierung
WO2017031278A1 (en) * 2015-08-18 2017-02-23 Centrillion Technology Holdings Corporation Probe inversion process for in situ synthesized probe arrays
US10695735B2 (en) 2015-08-18 2020-06-30 Centrillion Technology Holdings Corporation Probe inversion process for in situ synthesized probe arrays
BR112020021218A2 (pt) 2018-04-18 2021-03-02 St. Jude Children's Research Hospital ensaios de genotipagem para identificar mutações em xaf1
US11384376B2 (en) * 2018-05-31 2022-07-12 Roche Molecular Systems, Inc. Reagents and methods for post-synthetic modification of nucleic acids
CN113195639A (zh) * 2018-12-20 2021-07-30 生命技术公司 非对称罗丹明染料和其在生物测定中的用途
WO2021230293A1 (ja) * 2020-05-13 2021-11-18 住友化学株式会社 無機多孔質基材、無機多孔質担体、および核酸の製造方法
US11787831B2 (en) * 2020-06-22 2023-10-17 Illumina Cambridge Limited Nucleosides and nucleotides with 3′ acetal blocking group
EP4185596A1 (de) 2020-07-23 2023-05-31 Life Technologies Corporation Energieübertragungsfarbstoffkonjugate zur verwendung in biologischen tests
WO2022020731A2 (en) 2020-07-23 2022-01-27 Life Technologies Corporation Compositions, systems and methods for biological analysis involving energy transfer dye conjugates and analytes comprising the same
CN116333006A (zh) * 2023-04-07 2023-06-27 苏州欧利生物医药科技有限公司 一种带有荧光标记物的寡核苷酸的固相合成方法
CN119350418A (zh) * 2024-12-24 2025-01-24 中肽生化有限公司 一种寡核苷酸的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367066A (en) 1984-10-16 1994-11-22 Chiron Corporation Oligonucleotides with selectably cleavable and/or abasic sites
US4965349A (en) 1987-12-24 1990-10-23 Applied Biosystems, Inc. Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
US5141813A (en) 1989-08-28 1992-08-25 Clontech Laboratories, Inc. Multifunctional controlled pore glass reagent for solid phase oligonucleotide synthesis
US5290925A (en) * 1990-12-20 1994-03-01 Abbott Laboratories Methods, kits, and reactive supports for 3' labeling of oligonucleotides
US5371241A (en) 1991-07-19 1994-12-06 Pharmacia P-L Biochemicals Inc. Fluorescein labelled phosphoramidites
JPH0649100A (ja) * 1992-05-06 1994-02-22 Eastman Kodak Co カルボキシル化基体への化合物の結合方法
US5552471A (en) 1994-08-17 1996-09-03 The Perkin-Elmer Corporation Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides
FI970696A0 (fi) * 1994-09-02 1997-02-19 Ciba Geigy Ag Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi
US5908926A (en) * 1995-03-16 1999-06-01 Duke University 5'to 3' nucleic acid synthesis using 3'-photoremovable protecting group
US5736626A (en) * 1996-01-29 1998-04-07 The Perkin-Elmer Corporation Solid support reagents for the direct synthesis of 3'-labeled polynucleotides
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
JP2007161641A (ja) * 2005-12-14 2007-06-28 Pola Chem Ind Inc 液体洗浄料

Also Published As

Publication number Publication date
US20050191660A1 (en) 2005-09-01
DE60005646D1 (de) 2003-11-06
DK1155027T3 (da) 2003-12-29
US20020165389A1 (en) 2002-11-07
CA2353047C (en) 2009-01-20
US6525183B2 (en) 2003-02-25
DE60005646T2 (de) 2004-08-05
WO2000050432A3 (en) 2001-02-01
US6255476B1 (en) 2001-07-03
JP2002537401A (ja) 2002-11-05
US20030191303A1 (en) 2003-10-09
US6835827B2 (en) 2004-12-28
US20010014735A1 (en) 2001-08-16
ES2204537T3 (es) 2004-05-01
JP4634615B2 (ja) 2011-02-16
JP2011084573A (ja) 2011-04-28
WO2000050432A2 (en) 2000-08-31
JP2007131642A (ja) 2007-05-31
US6316610B2 (en) 2001-11-13
EP1155027B1 (de) 2003-10-01
CA2353047A1 (en) 2000-08-31
EP1155027A2 (de) 2001-11-21
JP2007131641A (ja) 2007-05-31
AU773864B2 (en) 2004-06-10
AU3369100A (en) 2000-09-14

Similar Documents

Publication Publication Date Title
ATE251174T1 (de) Synthese von markierten oligonucleotiden auf festphasenträgern
Sinha et al. The preparation and application of functionalised synthetic oligonucleotides: III. Use of H-phosphonate derivatives of protected amino-hexanol and mercapto-propanol or-hexanol
US5290925A (en) Methods, kits, and reactive supports for 3' labeling of oligonucleotides
CA1310600C (en) Oligonucleotide functionalizing reagents and methods
US4962029A (en) Covalent oligonucleotide-horseradish peroxidase conjugate
CA2627216C (en) Polynucleotide labelling reagent
EP0954606B1 (de) Nicht-Nukleotid verknüpfende Reagentien
US5916750A (en) Multifunctional linking reagents for synthesis of branched oligomers
EP1152008A3 (de) Fluoreszente Nucleotide, enthaltend einen Cyanin, Merocyanin- oder Styryl-Farbstoff, zur Erkennung von Nucleinsäuren
Thuong et al. Solid phase synthesis of oligo-α-and oligo-β-deoxynucleotidescovalently linked to an acridine
IL127556A0 (en) Enzymatically cleavable linkers for solid-phase syntheses
EP1152010A3 (de) Oligonukleotidmarkierungsstoffe und ihre Verwendung
Vo-Quang et al. Towards new inhibitors of D-alanine: D-alanine ligase: The synthesis of 3-amino butenylphosphonic and aminophosphonamidic acids.
DE69823657D1 (de) Zur herstellung von sulfurierten oligonukleotidanaloga
Acedo et al. Preparation of oligonucleotide-dexamethasone conjugates
MXPA01004672A (es) Agentes de reticulacion de polinucleotido.
AU2006316903B2 (en) Polynucleotide labelling reagent
EP1308452A3 (de) Oligonukleotidmarkierungsreagenzien auf der Basis von azyklischen Nukleosiden, und deren derivatisierte Konjugate
EP1809647A2 (de) Amino- oder thiollinkerbaustein für die synthese von amino- oder thiolfunktionalisierten nukleinsäuren und verfahren zu deren herstellung und anwendung
JP2003171396A (ja) 新規な機能性ペプチド核酸およびその製法
WO2000031102A1 (en) Oligonucleotide conjugation
Harwig et al. A one-pot multistep approach to α-azido-phosphonate and phosphonothioate diesters: key intermediates in the synthesis of haptens for the generation of antibody ligases
CA2384191A1 (en) Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto
US20040249152A1 (en) Method for the production of cna

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties